Literature DB >> 14557580

Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD.

J Eerola1, D Hernandez, J Launes, O Hellström, S Hague, C Gulick, J Johnson, T Peuralinna, J Hardy, P J Tienari, A B Singleton.   

Abstract

Mutations in DJ-1 are a cause of autosomal recessive parkinsonism. Polymorphism of genes implicated in hereditary forms of parkinsonism may be a predisposing factor in sporadic Parkinson's disease (PD). The authors analyzed whether a polymorphism (g.168_185del) within exon 1 of DJ-1 contributes to the risk of sporadic PD in a Finnish case-control series. This gene does not play a major role in the genetic predisposition to PD in this population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557580     DOI: 10.1212/01.wnl.0000083992.28066.7e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Screening of two indel polymorphisms in the 5'UTR of the DJ-1 gene in South African Parkinson's disease patients.

Authors:  Brigitte Glanzmann; Debbie Lombard; Jonathan Carr; Soraya Bardien
Journal:  J Neural Transm (Vienna)       Date:  2013-09-20       Impact factor: 3.575

2.  Genetic polymorphisms and haplotypes of the DJ-1 gene promoter associated with the susceptibility to male infertility.

Authors:  Danial Jahantigh; Abasalt Hosseinzadeh Colagar; Saeedeh Salimi
Journal:  J Assist Reprod Genet       Date:  2017-09-20       Impact factor: 3.412

3.  DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.

Authors:  Sara Batelli; Diego Albani; Raffaela Rametta; Letizia Polito; Francesca Prato; Marzia Pesaresi; Alessandro Negro; Gianluigi Forloni
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

4.  Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.

Authors:  C Paisán-Ruíz; E W Evans; S Jain; G Xiromerisiou; J R Gibbs; J Eerola; V Gourbali; O Hellström; J Duckworth; A Papadimitriou; P J Tienari; G M Hadjigeorgiou; A B Singleton
Journal:  J Med Genet       Date:  2006-02       Impact factor: 6.318

5.  A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

Authors:  Alessandro Bonetti; Keijo Koivisto; Tuula Pirttilä; Irina Elovaara; Mauri Reunanen; Mikko Laaksonen; Juhani Ruutiainen; Leena Peltonen; Terhi Rantamäki; Pentti J Tienari
Journal:  J Neuroimmunol       Date:  2009-02-04       Impact factor: 3.478

6.  Neurofibrillary tau pathology modulated by genetic variation of alpha-synuclein.

Authors:  Terhi Peuralinna; Minna Oinas; Tuomo Polvikoski; Anders Paetau; Raimo Sulkava; Leena Niinistö; Hannu Kalimo; Dena Hernandez; John Hardy; Andrew Singleton; Pentti J Tienari; Liisa Myllykangas
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

7.  Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.

Authors:  Conceição Bettencourt; Cristina Santos; Paula Coutinho; Patrizia Rizzu; João Vasconcelos; Teresa Kay; Teresa Cymbron; Mafalda Raposo; Peter Heutink; Manuela Lima
Journal:  BMC Neurol       Date:  2011-10-24       Impact factor: 2.474

8.  Genetic analysis of indel markers in three loci associated with Parkinson's disease.

Authors:  Zhixin Huo; Xiaoguang Luo; Xiaoni Zhan; Qiaohong Chu; Qin Xu; Jun Yao; Hao Pang
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

9.  Identification of a novel functional deletion variant in the 5'-UTR of the DJ-1 gene.

Authors:  Rowena J Keyser; Lize van der Merwe; Mauritz Venter; Craig Kinnear; Louise Warnich; Jonathan Carr; Soraya Bardien
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

10.  Association between a DJ-1 polymorphism and the risk of Parkinson's disease: a PRISMA-compliant systematic review and meta-analysis.

Authors:  Jie Liu; Chunrong Li; Xiaoyang Zhou; Jian Sun; Meng Zhu; Hongliang Zhang; Lei Cheng; Guobin Li; Tao He; Wenshuai Deng
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.